RILYO:NSD-B Riley Financial Inc

ETF | Others | NSD

Last Closing Price

USD 25.34

Change

+0.04 (+0.15)%

Market Cap

N/A

Volume

0.02M

Average Target Price

N/A
Average Analyst Rating

N/A

STA Verdict

Verdict

About

Market Stats

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-14 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
BNTX BioNTech SE 0.00 %

-1.07 (-7.74%)

N/A
FREQ Frequency Therapeutics, Inc 0.00 %

+0.36 (+2.77%)

N/A
HBT HBT Financial, Inc 0.00 %

-0.04 (-0.26%)

N/A
OPRT Oportun Financial Corporation 0.00 %

+0.02 (+0.13%)

N/A
VIE Viela Bio, Inc 0.00 %

-0.45 (-2.34%)

N/A
VIR Vir Biotechnology, Inc 0.00 %

-0.23 (-1.64%)

N/A
ALFC Alfacourse Inc 0.00 %

N/A

N/A
AMRQQ Alta Mesa Resources, Inc 0.00 %

-0.01 (-23.53%)

N/A
AMRWQ Alta Mesa Resources, Inc 0.00 %

N/A

N/A
BSML Invesco BulletShares (R) 2021 .. 0.00 %

N/A

N/A

ETFs Containing RILYO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike